United States · FDA National Drug Code directory
Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64980-104_6e5bf656-cf34-4279-b2f4-7c1893cf7275
- Product NDC
- 64980-104
- Form
- TABLET
- Composition / generic term
- Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20120628 / 20281231
Source-listed ingredients
- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS — 852 mg/1
- POTASSIUM PHOSPHATE, MONOBASIC — 155 mg/1
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE — 130 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (64980-104-01) · 64980-104-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →